2023
DOI: 10.1016/j.xjon.2023.09.031
|View full text |Cite
|
Sign up to set email alerts
|

Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome

Rachel E. Wittenberg,
Kimberlee Gauvreau,
Jonah Leighton
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 26 publications
0
0
0
Order By: Relevance